Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Samuel Isaly’s New Healthcare Positions: Community Health Systems (CYH), Glaukos Corp (GKOS), More

Samuel Isaly’s OrbiMed Advisors is a healthcare fund with $15 billion worth of assets under management. The investment advisory firm has experience of over two decades of investing in biopharmaceuticals, healthcare services, medical devices, and firms specializing in medical diagnostics. According to its website, the healthcare fund has been active in private healthcare investing since 1993 and its latest SEC 13F filing acknowledges a public equity portfolio with holdings tallying $11.96 billion. The healthcare fund has 95% of its equity investments in the healthcare industry, with its top ten stock holdings accounting for 36.54% of its overall portfolio. While looking at the equity portfolio of OrbiMed Advisors, we identified Community Health Systems (NYSE:CYH), Glaukos Corp (NYSE:GKOS), and Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) as the top new stock positions of the fund during the second quarter.

Samuel Isaly - Orbimed Advisors

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically delivered a monthly alpha of six basis points, though these stocks underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read the details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 118% and beating the market by more than 60 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise rather than large-cap stocks.

Samuel Isaly
Samuel Isaly
OrbiMed Advisors

Community Health Systems (NYSE:CYH) is the top new stock position of OrbiMed Advisors, with the fund holding 1.53 million shares valued at $96.34 million. Community Health Systems is a hospital company with a chain of acute care hospitals throughout the country. The firm operates under two different segments: hospital operations and home care services. Community Health Systems (NYSE:CYH) is planning to spin-off Quorum Health Resources, which provides management and consulting services to hospitals. The spin-off is likely to be completed in the first quarter of 2016. Wayne T. Smith, CEO and chairman of Community Health Systems (NYSE:CYH), said, “This significant transaction will realign our portfolio into two strong and focused companies that can respond to market demands with greater agility and that are better positioned to take advantage of growth opportunities, while creating additional value for our stockholders.” The company was able to outperform Wall Street’s earnings estimates for the second quarter of 2015 with its EPS of $1.14 beating the expectations of $0.91. Its revenue was a little shy of the markets’ estimate however, with reported revenues of $4.90 billion. Larry Robbins’ of Glenview Capital is the largest shareholder of Community Health Systems (NYSE:CYH) in our database, owning 12.09 million shares valued at $761.55 million at the end of the second quarter.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.